47 related articles for article (PubMed ID: 18194865)
1. Discovery of Novel Steroid-Based Histamine H
Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Barabás J; Béni Z; Varga B; Balázs O; Román V; Fodor L; Szikra J; Vastag M; Lévay G; Schmidt É; Lendvai B; Greiner I; Kiss B; Némethy Z; Mahó S
J Med Chem; 2024 Mar; 67(5):3643-3667. PubMed ID: 38393759
[TBL] [Abstract][Full Text] [Related]
2. 4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H
Wágner G; Mocking TAM; Arimont M; Provensi G; Rani B; Silva-Marques B; Latacz G; Da Costa Pereira D; Karatzidou C; Vischer HF; Wijtmans M; Kieć-Kononowicz K; de Esch IJP; Leurs R
J Med Chem; 2019 Dec; 62(23):10848-10866. PubMed ID: 31675226
[TBL] [Abstract][Full Text] [Related]
3. The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.
Zhao C; Sun M; Bennani YL; Gopalakrishnan SM; Witte DG; Miller TR; Krueger KM; Browman KE; Thiffault C; Wetter J; Marsh KC; Hancock AA; Esbenshade TA; Cowart MD
J Med Chem; 2008 Sep; 51(17):5423-30. PubMed ID: 18683917
[TBL] [Abstract][Full Text] [Related]
4. Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds.
Panda SS; Aziz MN; Stawinski J; Girgis AS
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677727
[TBL] [Abstract][Full Text] [Related]
5. Conessine Interferes with Oxidative Stress-Induced C2C12 Myoblast Cell Death through Inhibition of Autophagic Flux.
Kim H; Lee KI; Jang M; Namkoong S; Park R; Ju H; Choi I; Oh WK; Park J
PLoS One; 2016; 11(6):e0157096. PubMed ID: 27257813
[TBL] [Abstract][Full Text] [Related]
6. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
Panula P; Chazot PL; Cowart M; Gutzmer R; Leurs R; Liu WL; Stark H; Thurmond RL; Haas HL
Pharmacol Rev; 2015 Jul; 67(3):601-55. PubMed ID: 26084539
[TBL] [Abstract][Full Text] [Related]
7. 2-(3,3,4,4-Tetra-fluoro-pyrrolidin-1-yl)aniline.
Cao W; Zhong JW; Wang J; Liu PL; Zeng Z
Acta Crystallogr Sect E Struct Rep Online; 2011 Sep; 67(Pt 9):o2220. PubMed ID: 22058901
[TBL] [Abstract][Full Text] [Related]
8. A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin.
Kennedy JP; Conn PJ; Lindsley CW
Bioorg Med Chem Lett; 2009 Jun; 19(12):3204-8. PubMed ID: 19443215
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in histamine H3 receptor antagonists/inverse agonists.
Łazewska D; Kieć-Kononowicz K
Expert Opin Ther Pat; 2010 Sep; 20(9):1147-69. PubMed ID: 20716022
[TBL] [Abstract][Full Text] [Related]
10. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists.
Hancock AA
Biochem Pharmacol; 2006 Apr; 71(8):1103-13. PubMed ID: 16513092
[TBL] [Abstract][Full Text] [Related]
11. A new family of H3 receptor antagonists based on the natural product Conessine.
Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Sengupta D; Duffield JJ; Semple G; Webb RR; Sage C; Ren A; Pereira G; Knudsen J; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Whelan K; Grottick AJ
Bioorg Med Chem Lett; 2008 Feb; 18(4):1490-4. PubMed ID: 18194865
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.
Célanire S; Wijtmans M; Christophe B; Collart P; de Esch I; Dassesse D; Delaunoy C; Denonne F; Durieu V; Gelens E; Gillard M; Lallemand B; Lamberty Y; Lebon F; Nicolas JM; Quéré L; Snip E; Vanbellinghen A; Van Houtvin N; Verbois V; Timmerman H; Talaga P; Leurs R; Provins L
ChemMedChem; 2009 Jul; 4(7):1063-8. PubMed ID: 19405064
[TBL] [Abstract][Full Text] [Related]
13. Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H₃ receptor antagonists with potent cognition enhancing activity.
Tao M; Aimone LD; Huang Z; Mathiasen J; Raddatz R; Lyons J; Hudkins RL
J Med Chem; 2012 Jan; 55(1):414-23. PubMed ID: 22107017
[TBL] [Abstract][Full Text] [Related]
14. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
Gbahou F; Davenas E; Morisset S; Arrang JM
J Pharmacol Exp Ther; 2010 Sep; 334(3):945-54. PubMed ID: 20530654
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists.
Josef KA; Aimone LD; Lyons J; Raddatz R; Hudkins RL
Bioorg Med Chem Lett; 2012 Jun; 22(12):4198-202. PubMed ID: 22617490
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
